Fast Melt Tablets Market Report 2026

Fast Melt Tablets Market Overview

• Fast Melt Tablets market size has reached to $5.33 billion in 2025 • Expected to grow to $7.73 billion in 2030 at a compound annual growth rate (CAGR) of 7.7% • Growth Driver: Rising Heart Attack Cases Fueling The Growth Of The Market Due To Demand For Rapid-Acting Emergency Medications • Market Trend: Formulation Innovations And ODT Advancements Drive Growth In Fast Melt Tablets Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Fast Melt Tablets Market?

Fast melt tablets are oral dosage forms designed to dissolve quickly in the mouth without the need for water. They offer a convenient option for patients who have difficulty swallowing traditional tablets. These tablets disintegrate rapidly, typically within seconds, upon contact with saliva. Fast melt technology is often used in pediatric, geriatric, and travel-friendly medications. The main types of fast melt tablets include antipsychotics, antiepileptics, central nervous system (CNS) stimulants, anxiolytics, anti-parkinsonian drugs, antihypertensives, non-steroidal anti-inflammatory drugs (NSAIDs), anti-allergy drugs, proton pump inhibitors, and other types. Antipsychotics are medications that balance brain chemicals to manage schizophrenia, bipolar disorder, and related symptoms, often available as fast-melt tablets to improve adherence. These tablets are used for various indications, including pain management, allergy and respiratory disorders, neurological disorders, gastrointestinal disorders, cardiovascular disorders, and other conditions. These tablets come in different dosage forms, such as oral, sublingual, buccal, and chewable, and are used across various age groups, including adults, pediatrics, and geriatrics, and Distributed through hospital pharmacies, retail pharmacies, drug stores, and online pharmacies.

What Is The Fast Melt Tablets Market Growth Forecast?

The fast melt tablets market size is expected to see strong growth in the next few years. It will grow to $7.73 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increasing focus on patient compliance, rising neurological and psychiatric disorders, demand for convenient drug delivery systems, expansion of homecare medication use, innovation in oral thin-film technologies. Major trends in the forecast period include rising demand for patient-friendly oral dosage forms, increasing use in pediatric and geriatric medications, expansion of cns and pain management applications, growing preference for water-free drug administration, wider adoption in travel-friendly and emergency use.

Global Fast Melt Tablets Market Segmentation

1) By Type: Anti Psychotics, Anti Epileptics, Central Nervous System (CNS) Stimulants, Anxiolytics, Anti Parkinsonian Drugs, Anti Hypertensive, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Anti Allergy Drugs, Proton Pump Inhibitors, Other Types 2) By Indication: Pain Management, Allergy And Respiratory Disorders, Neurological Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Other Indications 3) By Dosage Form: Oral, Sublingual, Buccal, Chewable 4) By Age Group: Adult, Pediatrics, Geriatrics 5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies Subsegments: 1) By Anti Psychotics: Atypical Antipsychotics, Typical Antipsychotics 2) By Anti Epileptics: Sodium Channel Blockers, Gamma-Aminobutyric Acid (GABA) Analogs 3) By Central Nervous System (CNS) Stimulants: Amphetamines, Methylphenidate, Modafinil 4) By Anxiolytics: Benzodiazepines, Azapirones, Antihistamines 5) By Anti Parkinsonian Drugs: Dopamine Agonists, Monoamine Oxidase-B (MAO-B) Inhibitors, Anticholinergics 6) By Anti Hypertensive: Beta Blockers, Calcium Channel Blockers 7) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDS): Cyclooxygenase-1 (COX-1) Inhibitors 8) By Anti Allergy Drugs: Antihistamines, Leukotriene Receptor Antagonists 9) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole 10) By Other Types: Antiemetics, Antidepressants, Analgesics

What Is The Driver Of The Fast Melt Tablets Market?

The rising incidence of heart attacks is expected to propel the growth of the fast melt tablets market going forward. A heart attack refers to a medical emergency that occurs when blood flow to the heart muscle is blocked, usually due to a blood clot or buildup of plaque in the coronary arteries. The incidence of heart attacks is growing due to increased consumption of processed foods, which leads to higher cholesterol levels and arterial plaque buildup. Fast melt tablets provide rapid drug absorption, enabling quicker delivery of critical medications such as aspirin or nitroglycerin to help prevent further damage during a heart attack, improving patient outcomes by restoring blood flow and reducing the risk of severe complications. For instance, in September 2025, according to the British Heart Foundation, a UK-based cardiovascular research charity, there could be an additional one million people living with cardiovascular disease in the UK by 2030, rising to two million more than today by 2040. This marks the highest recorded figure. Therefore, the rising incidence of heart attacks is driving the growth of the fast melt tablets industry.

Key Players In The Global Fast Melt Tablets Market

Major companies operating in the fast melt tablets market are Pfizer Inc., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Unichem Laboratories Ltd., Lannett Company Inc., Perrigo Company plc, Catalent Inc., SPI Pharma Inc., Fuji Chemical Industries Co. Ltd., Melt Pharmaceuticals Inc., Akina Inc., Church & Dwight Co. Inc., Windmill Health Products LLC, The Procter & Gamble Company, Hikma Pharmaceuticals plc, Dr. Reddy’s Laboratories Ltd.

Global Fast Melt Tablets Market Trends and Insights

Major companies operating in the fast melt tablets market are focusing on formulation innovation, such as orally disintegrating tablet (ODT) technologies that enable rapid dissolution without water, to improve medication adherence, convenience, and accessibility for patients with chronic neurological conditions. Orally Disintegrating Tablet (ODT) Technology allows active ingredients to be delivered via a fast-melt format that breaks down on the tongue within seconds, offering ease of administration for patients who have difficulty swallowing traditional tablets or require discreet, portable dosing options. For instance, in February2023, Cycle Pharmaceuticals Ltd., a U.K.-based rare disease and specialty pharmaceuticals company, launched TASCENSO ODT (fingolimod), the first FDA-approved orally disintegrating tablet for treating relapsing forms of multiple sclerosis (MS) in patients aged 10 years and older. Developed using Catalent’s ZYDIS fast-dissolve platform, the bioequivalent non-generic ODT ensures continuity of care for U.S. patients losing access to Gilenya support services and is supported by Cycle’s dedicated patient platform, Cycle Vita, offering co-pay assistance, bridge programs, and in-home baseline assessments to maintain uninterrupted fingolimod therapy.

What Are Latest Mergers And Acquisitions In The Fast Melt Tablets Market?

In September 2023, Melt Pharmaceuticals, Inc., a US-based clinical-stage pharmaceutical company, entered into a licensing agreement with Catalent Inc. Through this partnership, Melt will leverage Catalent’s proprietary Zydis orally disintegrating tablet technology to develop a sublingual, needle-free, and opioid-free formulation combining midazolam and ketamine. Catalent Inc. is a US-based drug development and delivery solutions company specializing in biologics, gene therapies, and oral, inhalation, and injectable drug delivery technologies.

Regional Insights

North America was the largest region in the fast melt tablets market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Fast Melt Tablets Market?

The fast melt tablets market consists of sales of orally disintegrating tablets (ODTs), prescription medications, and over-the-counter (OTC) medications. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Fast Melt Tablets Market Report 2026?

The fast melt tablets market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the fast melt tablets industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.